G1 Therapeutics, Inc(NASDAQ:GTHX) 
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult ...
Website: http://www.g1therapeutics.com
Founded: 2008
Full Time Employees: 104
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-03-21
P
O 3.45
H 3.74
L 3.45
C 3.70
V 990,191
10EMA 3.70
20EMA 3.70
60EMA 3.70
120EMA 3.70
250EMA 3.70